Anduril’s Arsenal-1 Is Now Producing Fury — Three Months Early, and the $20B Contract Changes the Calculus

The most important fact buried beneath the US-China rhetoric is operational: Anduril has begun serial production of the YFQ-44A Fury Collaborative Combat Aircraft at Arsenal-1 in Ohio, approximately three months ahead of its previously stated Q2 2026 schedule, while simultaneously absorbing a 10-year, $20 billion ceiling contract from the Department of the Army for AI-powered counter-UAS — a single procurement vehicle that consolidates over 120 prior acquisition actions.

The production acceleration at Arsenal-1 — a nearly $1 billion, 1.7 million square-foot facility in Pickaway County — is the most concrete validation yet of Anduril’s manufacturing thesis. Initial Fury output is targeted at 50 aircraft annually, scaling to 150 per year, with Roadrunner interceptors and Barracuda cruise missiles also coming off the same lines by end of 2026. This matters because Anduril’s bull case has always rested on a single execution risk: whether a nine-year-old company could transition from prototype to high-rate production without the legacy infrastructure of a Lockheed Martin or Boeing. The early production start, combined with 250+ workers already on-site, suggests that risk is diminishing faster than most observers modeled. Separately, Anduril’s counter-drone Fly-Away Kit was operationally deployed by NORTHCOM during Operation Epic Fury to defeat a drone incursion over a U.S. strategic installation — providing live combat validation that no press release can replicate.

The $20 billion Army contract, with an initial $87 million task order to JIATF 401, structurally transforms Anduril’s revenue profile. Where the January 2025 Pentagon counter-UAS award — $250 million for 500 Roadrunner interceptors plus Pulsar EW — established product-market fit, the new framework contract establishes Anduril as a preferred enterprise vendor across the Army’s counter-UAS stack for a decade. That kind of programmatic anchor is what converts a defense startup into a defense prime. The executive commentary on US legislative failures and Chinese strategic competition is, in this context, less a policy argument than a procurement argument: Anduril is telling Congress that the alternative to funding Arsenal-1’s output is ceding the autonomous systems production race to a Chinese industrial base that faces no equivalent legislative friction. The UK expansion — 100+ employees, pursuit of a £100 million Nyx autonomous collaborative platform contract, and a planned systems integration lab — signals Anduril is simultaneously building the allied-nation sales pipeline that would further justify Arsenal-1’s scale.

BOTTOM LINE

Defense procurement officers and program managers with counter-UAS or CCA equities should treat the $20 billion Army framework contract as the primary on-ramp for autonomous systems acquisition over the next decade and begin task order planning accordingly, while tracking the USAF CCA downselect as the next binary event that will determine whether Fury becomes a program of record or a niche production run.

Confidence: HIGH — Multiple independent sources confirm Arsenal-1 production start, the $20 billion contract ceiling is documented across defense trade outlets, and the NORTHCOM operational deployment provides third-party validation of counter-UAS capability; the primary uncertainty is whether Fury survives the USAF competitive downselect, which remains unresolved.

Source: https://www.defensenews.com/global/asia-pacific/2026/03/24/us-legislative-failures-are-giving-china-a-strategic-edge-anduril-exec-says/

Product Portfolio — Anduril

Signal Activity — Anduril

Deal History — Anduril

Competitive Positioning — Anduril